Cobimetinib impairs tumor survival and immune escape by altering my-CAFs in BRAFV600E-mutated anaplastic thyroid carcinoma
- DOI
- 10.24406/publica-11094
- Published
- 2026
- Container
- Not recorded
- Publisher
- Fraunhofer-Gesellschaft
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.24406/publica-11094,
title = {Cobimetinib impairs tumor survival and immune escape by altering my-CAFs in BRAFV600E-mutated anaplastic thyroid carcinoma},
author = {Udinotti, Mario and Ramm, Niclas and Hamdan, Thamer Abed Alhaleem Amin and Khan, Muhammad Sameer Ali and Siebolts, Udo and Bauer, Marcus and Lorenz, Kerstin and Dierks, Christine and Wickenhauser, Claudia and Seliger, Barbara and :unav},
year = {2026},
doi = {10.24406/publica-11094},
url = {https://doi.org/10.24406/publica-11094}
}RIS
TY - JOUR TI - Cobimetinib impairs tumor survival and immune escape by altering my-CAFs in BRAFV600E-mutated anaplastic thyroid carcinoma AU - Udinotti, Mario AU - Ramm, Niclas AU - Hamdan, Thamer Abed Alhaleem Amin AU - Khan, Muhammad Sameer Ali AU - Siebolts, Udo AU - Bauer, Marcus AU - Lorenz, Kerstin AU - Dierks, Christine AU - Wickenhauser, Claudia AU - Seliger, Barbara AU - :unav PY - 2026 DO - 10.24406/publica-11094 UR - https://doi.org/10.24406/publica-11094 ER -
APA
Mario, U., Niclas, R., Amin, H. T. A. A., Ali, K. M. S., Udo, S., Marcus, B., Kerstin, L., Christine, D., Claudia, W., Barbara, S., & :unav (2026). Cobimetinib impairs tumor survival and immune escape by altering my-CAFs in BRAFV600E-mutated anaplastic thyroid carcinoma. https://doi.org/10.24406/publica-11094
Source records
- datacite · retrieved 2026-11-08T15:44:50.453Z